We demonstrated that the inhibitors greatly decreased c-Myc expression and boosted viral replication and oncolysis in PDAC cells and cancer-associated fibroblasts (CAFs) in 3-dimensional co-cultures (3D) and in vivo murine xenograft models. The gene discussed is MYC; the disease is cancer.